Off the street phasing (OTSP): no hassle haplotype phasing for molecular PGD applications
- 22 Downloads
Pre-implantation genetic diagnosis (PGD) for molecular disorders requires the construction of parental haplotypes. Classically, haplotype resolution (“phasing”) is obtained by genotyping multiple polymorphic markers in both parents and at least one additional relative. However, this process is time-consuming, and immediate family members are not always available. The recent availability of massive genomic data for many populations promises to eliminate the needs for developing family-specific assays and for recruiting additional family members. In this study, we aimed to validate population-assisted haplotype phasing for PGD.
Targeted sequencing of CFTR gene variants and ~ 1700 flanking polymorphic SNPs (± 2 Mb) was performed on 54 individuals from 12 PGD families of (a) Full Ashkenazi (FA; n = 16), (b) mixed Ashkenazi (MA; n = 23 individuals with at least one Ashkenazi and one non-Ashkenazi grandparents), or (c) non-Ashkenazi (NA; n = 15) descent. Heterozygous genotype calls in each individual were phased using various whole genome reference panels and appropriate computational models. All computationally derived haplotype predictions were benchmarked against trio-based phasing.
Using the Ashkenazi reference panel, phasing of FA was highly accurate (99.4% ± 0.2% accuracy); phasing of MA was less accurate (95.4% ± 4.5% accuracy); and phasing of NA was predictably low (83.4% ± 6.6% accuracy). Strikingly, for founder mutation carriers, our haplotyping approach facilitated near perfect phasing accuracy (99.9% ± 0.1% and 98.2% ± 2.8% accuracy for W1282X and delF508 carriers, respectively).
Our results demonstrate the feasibility of replacing classical haplotype phasing with population-based phasing with uncompromised accuracy.
KeywordsPGD Haplotype phasing Population-based phasing Identity by descent CFTR
The authors thank the Shaare Zedek Mirsky intramural grant and Rabbi David Fuld for funding this research. S. C. thanks the Israel Science Foundation grant 407/17.
Compliance with ethical standards
All individuals agreed to use their DNA samples for this study, and ethical approval was obtained according to Shaare Zedek Medical Center institutional review board guidelines.
- 2.Yan L, Huang L, Xu L, Huang J, Ma F, Zhu X, et al. Live births after simultaneous avoidance of monogenic diseases and chromosome abnormality by next-generation sequencing with linkage analyses. Proc Natl Acad Sci U S A. 2015;112(52):15964–9. https://doi.org/10.1073/pnas.1523297113.CrossRefPubMedPubMedCentralGoogle Scholar
- 3.Thornhill AR, Handyside AH, Ottolini C, Natesan SA, Taylor J, Sage K, et al. Karyomapping-a comprehensive means of simultaneous monogenic and cytogenetic PGD: comparison with standard approaches in real time for Marfan syndrome. J Assist Reprod Genet. 2015;32(3):347–56. https://doi.org/10.1007/s10815-014-0405-y.CrossRefPubMedPubMedCentralGoogle Scholar
- 5.Natesan SA, Handyside AH, Thornhill AR, Ottolini CS, Sage K, Summers MC, et al. Live birth after PGD with confirmation by a comprehensive approach (karyomapping) for simultaneous detection of monogenic and chromosomal disorders. Reprod BioMed Online. 2014;29(5):600–5. https://doi.org/10.1016/j.rbmo.2014.07.007.CrossRefPubMedGoogle Scholar
- 6.Natesan SA, Bladon AJ, Coskun S, Qubbaj W, Prates R, Munne S, et al. Genome-wide karyomapping accurately identifies the inheritance of single-gene defects in human preimplantation embryos in vitro. Genet Med. 2014;16(11):838–45. https://doi.org/10.1038/gim.2014.45.CrossRefPubMedPubMedCentralGoogle Scholar
- 7.Handyside AH, Harton GL, Mariani B, Thornhill AR, Affara N, Shaw MA, et al. Karyomapping: a universal method for genome wide analysis of genetic disease based on mapping crossovers between parental haplotypes. J Med Genet. 2010;47(10):651–8. https://doi.org/10.1136/jmg.2009.069971.CrossRefPubMedGoogle Scholar
- 32.SHAPEIT. https://mathgen.stats.ox.ac.uk/genetics_software/shapeit/shapeit.html#home. Accessed July 19, 2018 2018.
- 37.Genome England. http://genomicsengland.co.uk. Accessed 2018 2018.
- 38.All of Us. https://allofus.nih.gov/. 2018.
- 40.Korean Reference Genome Project. http://126.96.36.199/KRGDB/menuPages/intro.jsp. 2018.
- 43.Worldwide survey of the delta F508 mutation—report from the cystic fibrosis genetic analysis consortium. Am J Hum Genet. 1990;47(2):354–9.Google Scholar
- 44.Wu D, Dou J, Chai X, Bellis C, Wilm A, Shih CC, et al. Large-scale whole-genome sequencing of three diverse Asian populations in Singapore. bioRxiv. 2018. https://doi.org/10.1101/390070.